Although approximately 70% of breast cancer patients whose primary tumours are positive for the presence of oestrogen receptors (ER) and progesterone receptors (PGR) respond to hormonal therapy (Clark & McGuire, 1983) , virtually all will ultimately become resistant to this treatment.
Treatment failure may be associated with a variety of changes in tumour characteristics leading to a more malignant phenotype, including the development of anti-oestrogen resistance (Nawata et al., 1981; Bronzert et al., 1985; van den Berg et al., 1989 ) and progression to oestrogen independence. Stepwise progression from hormone dependence to independence has been extensively investigated in rodent mammary (Sluyser & Van Nie, 1974; Darbre & King, 1988) and prostatic (Humphries & Isaacs, 1982) cancers. Similar observations in human breast cancer growing in long-term culture have only been possible since the discovery that the pH indicator phenol red acts as a weak oestrogen (Berthois et al., 1986) . Both MCF-7 (Katzenellenbogen et al., 1987) and ZR-75-1 (Glover et al., 1988) human breast cancer cells respond to transfer to oestrogen and phenol red free medium with a slowing of growth rate and loss of PGR. Growth rate is markedly accelerated by oestradiol-1 7p (E2) treatment which also induces PGR synthesis. In these short-term oestrogen deprived cells anti-oestrogens appear to act as partial agonists/antagonists. Prolonged culture of MCF-7 cells under oestrogen free conditions results in an increased rate of cell proliferation which is unaffected by E2, although PGR synthesis remains E2 dependent (Katzenellenbogen et al., 1987; Welshons & Jordan, 1987) . This adaptation to oestrogen independent growth is also associated with an increase in ER expression and retention of sensitivity to the antiproliferative effects of anti-oestrogens.
In this study we have examined the response of ZR-75-1 cells to prolonged oestrogen withdrawal. We report that adaptation of ZR-75-1 cells to oestrogen free growth results in loss of specific binding sites for E2 characteristic of type 1 receptors and that this is accompanied by a marked elevation of PGR levels. We also describe the effects of E2, 4-hydroxy tamoxifen and medroxyprogesterone acetate (MPA) on cell proliferation in short and long term oestrogen deprived cells.
Materials and methods

Cell lines
The Receptor assays and drug effects on cell proliferation ER and PGR expression was determined using a whole cell binding assay at 37'C as previously described (van den Berg et al., 1987 Limits of detection were 10 and 15 fmol mg-' protein for PGR and ER respectively.
The effects of continuous drug treatment on cell proliferation was assessed by growing cells in microwell dishes (well surface area 2 cm2). After trypsinisation cell numbers were determined using a Coulter Counter Model D (Coulter Electronics, Luton, Beds., UK.).
Results
The effect of E2 on the proliferation of ZR-75-1 cells after short and long-term E2 withdrawal Figure 1 shows the effect of short and long-term oestrogen deprivation on the response of ZR-75-1 to a physiological and pharmacological concentration of E2. Within 5 days of transfer to oestrogen free medium proliferation of ZR-75-1 cells slowed markedly, with the doubling time extending from approximately 2 to 8 days. E2 at 10-M, which is only marginally growth stimulatory in the presence of phenol red and serum associated oestrogens, significantly stimulates the proliferation of short-term oestrogen deprived cells. E2 at 10-6M inhibits growth of both populations. ZR-75-1 cells continued to proliferate slowly in oestrogen free medium for three months, at which point growth virtually ceased. Over the following 2 months a number of flasks were lost as a result of unsuccessful attempts to subculture. Three 75 cm2 flasks survived and after approximately 5 months in oestrogen free medium growth rate rapidly increased and the cells took on a healthy epithelial appearance under phase contrast microscopy. There was no evidence of selective colony growth and cells have not been cloned. Population doubling time for these adapted cells is indistinguishable from that of the parent line despite being grown in phenol red-free RPMI supplemented with 5% FCSdcc (Figure 1) . While 10-6 M E2 again inhibits cell proliferation, 10-9 M E2 not only fails to stimulate growth but is itself slightly growth inhibitory.
ER and PGR expression in short and long-term E2 deprived ZR-75-1 cells The effect of short and long-term deprivation of oestrogens on ER and PGR expression in ZR-75-1 cells in shown in Table I .
In the presence of phenol red and unstripped ZR-75-1 cells express ER (Kd 0.62 ± 0.15 nM) and low levels of PGR (Kd 0.24 ± 0.08 nM). PGR expression increases 10-15-fold during a 5 day exposure to 10-9 M E2. Simultaneous exposure of ZR-75-1 cells to 10-9 M E2 and 10-9 M MPA results in only a 2-fold increase in PGR levels. Transfer of cells to oestrogen free medium for 5 days has no significant effect on ER expression while PGR is no longer detectable, but can be induced by E2 treatment. In cells adapted to growth in (Figure 1 ) and PGR expression induced (Table I ) by E2 exposure (Berthois et al., 1986) . We also confirm that 4-hydroxy tamoxifen inhibits proliferation further (Glover et al., 1988) . Partial agonist effects are only sponse of observed at lower concentrations than those used in this study (Katzenellenbogen et al., 1987) . for 5 days is Adaptation of ZR-75-1 cells to growth in the apparent droxy tamox-absence of oestrogens occured over a very similar time period e absence of to that reported for MCF-7 cells (Katzenellenbogen et (Figure 2 ). The nature of s an approx-these binding sites is unknown at present but they may e 5).
represent partial occupation of low affinity, high capacity erative effects type 2 ER (Panko et al., 1981) .
*e 6). In the Despite the apparent absence of type 1 ER and routine PA is growth maintanance in medium lacking oestrogenic activity, PGR pntrast, MPA expression by ZR-PR-LT cells is at a level normally ration of ZR-associated with E2 induction (Table I and Figure 3) . A igher concen-variant of the T47-D human breast cancer cell line has been gen free con-described which also contains very high concentrations of luced growth PGR despite virutally undetectable ER (Horwitz et al., 1982) .
Progestins down regulate PGR in these cells by a combina-0 tion of increased receptor degradation and decreased rate of A^s ynthesis (Nardulli et al., 1988) . MPA induced down regulation of PGR is also apparent in ZR-PR-LT cells (Table I) . Proliferation of ZR-PR-LT cells is inhibited by 4-hydroxy tamoxifen despite loss of binding sites characteristic of type 1 ER. There is considerable evidence that anti-oestrogens and E2 induce different conformational changes in ER (Hansen & Gorski, 1986) and it has been suggested that different ligand binding domains may be involved (Martin et al., 1988) . The ability of anti-oestrogens to inhibit the proliferation of breast cancer cells adapted to growth in the apparent absence of oestrogens has been consistently observed (Katzenellenbogen et al., 1987; Welshons et al., 1987) and supports the proposal that anti-oestrogens should be considered as receptor proliferation targeted drugs (Rochefort, 1987 (Manni et al., 1987; Braunsberg et al., 1987) .
T
Although PGR is believed to be important in mediating the 0 anti-proliferative effects of progestins (Schneider et al., 1989) other mechanisms may be involved, including interaction \\o with the glucocorticoid receptor (Braunsberg et al., 1987) .
\
We show that MPA is growth inhibitory towards ZR-75-1 s^cells growing in complete medium (Figure 6 ). In the shortterm absence of oestrogenic activity, however, low concentrations of MPA are growth stimulatory despite the absence of detectable PGR. These results are in agreement with an lo'-, 10'6 earlier report using T-47D human breast cancer cells (Hissom & Moore, 1987) , but the mechanism remains unclear. or that MPA is exerting its anti-proliferative effects through a mechanism distinct from PGR. A poor correlation between PGR concentration and response to progestins has been observed previously (Braunsberg et al., 1987; Reddel et al., 1988) . Our data confirm that acquisition of oestrogen independence does not necessarily imply anti-oestrogen resistance in human breast cancer cells in culture, but it remains to be established whether the selective pressure of complete oestrogen deprivation occurs in vivo. Nevertheless, the steroid hormone receptor profile and hormone sensitivity of ZR-PR-LT cells raise important questions concerning the mechanisms of action of anti-oestrogens and progestins in human breast cancer.
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